During the past decade, Hopital Bretonneau conducted 140 clinical trials. In the 10-year time frame, 140 clinical trials started and 26 clinical trials were completed, i.e. on average, 18.6% percent of trials that started reached the finish line to date. In the past 5 years, 69 clinical trials started and 19 clinical trials were completed. i.e. 27.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Bretonneau" #1 sponsor was "The Lymphoma Academic Research Organisation" with 14 trials, followed by "Groupe Francophone des Myelodysplasies" with 12 trials sponsored, "Nantes University Hospital" with 9 trials sponsored, "UNICANCER" with 9 trials sponsored and "Celgene" with 9 trials sponsored. Other sponsors include 163 different institutions and companies that sponsored additional 94 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Bretonneau" #1 collaborator was "Merck Sharp & Dohme LLC" with 6 trials as a collaborator, "Ministry of Health, France" with 6 trials as a collaborator, "Roche Pharma AG" with 6 trials as a collaborator, "Janssen-Cilag Ltd." with 5 trials as a collaborator and "National Cancer Institute, France" with 5 trials as a collaborator. Other collaborators include 107 different institutions and companies that were collaborators in the rest 98 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Bretonneau" are "Multiple Myeloma" (11 trials), "Myelodysplastic Syndromes" (8 trials), "Acute Myeloid Leukemia" (5 trials), "Prostate Cancer" (5 trials) and "HIV Infections" (4 trials). Many other conditions were trialed in "Hopital Bretonneau" in a lesser frequency.

Most popular intervention types in "Hopital Bretonneau" are "Drug" (148 trials), "Other" (32 trials), "Procedure" (11 trials), "Radiation" (11 trials) and "Device" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "placebo" (8 trials), "Dexamethasone" (7 trials), "Lenalidomide" (6 trials) and "Nintedanib" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Bretonneau" are 193 trials for "All" genders, 15 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Hopital Bretonneau". 5 are not yet recruiting, 49 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 106 completed trials in Hopital Bretonneau, 2 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Bretonneau, 8 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 29 trials that are defined as “Not Applicable".